Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Novartis AG ADS (NY: NVS)
73.82 USD  -0.80 (-1.07%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Novartis AG ADS
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
27 28 Next >
Bearish sentiment mounts as NVS is being investigated for health care fraud
October 26, 2011
Novartis AG (NVS - 56.83) saw eight times its average daily put volume Tuesday, with approximately 5,600 contracts crossing the tape...( Read More ) Read More
category NVS
from SchaeffersResearch.com Market Observations
Mylan Tops On All Fronts
October 26, 2011
Mylan Inc.’s (NYSE:MYL) third quarter 2011 earnings (excluding special items) of $0.55 per share surpassed the Zacks Consensus Estimate by $0.04 and the year-ago earnings by $0.12 per share. Earnings... Read More
category NVS , AZN , TEVA , and 5 more.
from DailyMarkets.com
Novartis Misses, Plans Job Cuts
October 25, 2011
Swiss pharmaceutical giant Novartis (NYSE:NVS) reported a lukewarm quarter delivering earnings per share of $1.45 for the third quarter of 2011, below the Zacks Consensus Estimate of $1.47 as well as... Read More
category RHHBY , External Research , Contributor , and 6 more.
from DailyMarkets.com
Roche’s MS Candidate Advances
October 24, 2011
Roche Holdings Ltd. (RHHBY) reported positive data from a mid-stage trial on ocrelizumab, which is also the second set of data that the company reported within a week. The candidate is being studied to... Read More
category NVS , RHHBY , Stocks , and 3 more.
from DailyMarkets.com
Novartis Higher Ahead of Earnings
October 24, 2011
New York, October 24th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) are trading higher by +0.17% ahead of its quarterly earnings release. Novartis, the Basel, Switzerland based... Read More
from TradersHuddle.com
Drug Companies Higher In Focus:NVO, GSK, NVS
October 20, 2011
New York, October 20th (TradersHuddle.com) - At the half of the trading session the market is trading lower with the S&P 500 losing 0.86%. Stocks of Pharmaceutical Companies are trading higher, with... Read More
from TradersHuddle.com
Novartis Bullish Engulfing Formed
October 19, 2011
New York, October 19th (TradersHuddle.com) - Shares of Novartis AG ( NYSE:NVS ) ended the trading session higher by $0.4 or 0.7% from its previous close. Novartis' price action formed what is... Read More
from TradersHuddle.com
Cooper Moves On With Avaira Recall
October 14, 2011
CooperVision, a unit of The Cooper Companies (NYSE:COO), a company focused on contact lens and women’s health, recently reported that it is still engaged with lens wearers, customers, distributors, eye... Read More
category NVS , jnj , COO , and 3 more.
from DailyMarkets.com
Generic Threat For Warner Chilcott
October 07, 2011
Warner Chilcott (NASDAQ:WCRX) recently announced that it received a paragraph IV patent certification notice from Zydus Pharmaceuticals USA Inc. regarding its drug Asacol HD (800 mg). The drug is... Read More
category NVS , IPXL , WCRX , and 3 more.
from DailyMarkets.com
Pharma Stocks Wrap Up - Higher: AZN, TEVA, NVO
October 06, 2011
New York, October 6th (TradersHuddle.com) - At the half of the trading session the market is trading higher with the S&P 500 adding 1.35%. Stocks of Pharmaceutical Companies are also trading higher,... Read More
from TradersHuddle.com
Two Novartis Drugs Cleared In Japan
October 05, 2011
Swiss pharma giant Novartis (NYSE:NVS) received a shot in the arm with two of its popular drugs receiving regulatory approval in Japan. The Ministry of Health, Labor and Welfare (MHLW) cleared Gilenya... Read More
category NVS , MKGAF , Stocks , and 3 more.
from DailyMarkets.com
Pharma Stocks Wrap Up - Higher: FRX, TEVA, NVO
October 05, 2011
New York, October 5th (TradersHuddle.com) - The market ended the trading session higher with the S&P 500 adding 1.79%. Stocks of Pharmaceutical Companies also traded higher, with NYSE Drug index ending... Read More
from TradersHuddle.com
Dr. Reddy’s, JB Chemicals End Deal
October 03, 2011
Dr. Reddy’s Laboratories (NYSE:RDY) recently announced that its deal with JB Chemicals & Pharmaceuticals regarding the latter’s prescription portfolio has been mutually terminated. According to the... Read More
category RDY , NVS , Stocks , and 2 more.
from DailyMarkets.com
Relief For Warner Chilcott
September 30, 2011
Recently, Warner Chilcott (NASDAQ:WCRX) received some encouraging news regarding its acne drug Doryx from a US district court. The court, while passing a verdict on Warner Chilcott’s patent dispute... Read More
category NVS , IPXL , WCRX , and 4 more.
from DailyMarkets.com
Novartis Shares More Positive Data
September 30, 2011
Novartis AG (NYSE:NVS) recently reported positive data from late-stage trials on pipeline candidate, NVA237, being studied for the treatment of chronic obstructive pulmonary disease (COPD). The data... Read More
category Stocks , External Research , Contributor
from DailyMarkets.com
Novartis Presents Afinitor Data
September 29, 2011
Novartis (NYSE:NVS) announced the presentation of data from a pivotal late stage study (BOLERO-2) which evaluated the use of Afinitor in combination with Pfizer’s (NYSE:PFE) Aromasin. The study... Read More
category AZN , RHHBY , External Research , and 5 more.
from DailyMarkets.com
Novo Nordisk - Worst Performing Pharmaceutical
September 28, 2011
New York, September 28th (TradersHuddle.com) - The market ended the trading session lower with the S&P 500 losing 2.07%. Stocks of Pharmaceutical Companies also traded lower, with NYSE Drug index... Read More
from TradersHuddle.com
Novartis Presents Afinitor Data
September 28, 2011
Novartis (NYSE:NVS) announced presentation of data from a pivotal late stage study (BOLERO-2) which evaluated the use of Afinitor in combination with Pfizer’s (NYSE:PFE) Aromasin. The study evaluated... Read More
category AZN , RHHBY , External Research , and 5 more.
from DailyMarkets.com
Kapitall Data Krunch: Novartis AG (NVS)
September 26, 2011
Novartis AG provides healthcare solutions worldwide. The company’s portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals, and consumer health... Read More
from Kapitall RSS Feed
Abbott Labs - Worst Performing Pharmaceutical
September 26, 2011
New York, September 26th (TradersHuddle.com) - At the half of the trading session the market is trading higher with the S&P 500 adding 1.08%. Stocks of Pharmaceutical Companies are also trading higher,... Read More
from TradersHuddle.com
(MNTA) Momenta Pharmaceuticals and Novartis AG Sue Watson Pharmaceuticals
September 24, 2011
Momenta Pharmaceuticals, Inc. (MNTA) and Novartis AG (NVS) filed a lawsuit against Amphastar... Visit StockBlogHub to view complete post. Read More
category Watson Pharmaceuticals Inc/ , AZN , Biotechnology , and 9 more.
from Stock Blog Hub
(MYL) Mylan Settles with Roche for Xeloda
September 23, 2011
Mylan Inc. (MYL) recently announced that it has entered into a settlement and license agreement... Visit StockBlogHub to view complete post. Read More
category Watson Pharmaceuticals Inc/ , Par Pharmaceutical Companies Inc , Mylan Inc/ , and 9 more.
from Stock Blog Hub
Sector Round Up - Pharmaceuticals Rise: BMY, SNY, AZN
September 23, 2011
New York, September 23rd (TradersHuddle.com) - At the half of the trading session the market is trading higher with the S&P 500 adding 0.57%. Stocks of Pharmaceutical Companies are also trading higher,... Read More
from TradersHuddle.com
Dr. Reddy’s Launches Generic Exelon
September 23, 2011
Dr. Reddy’s Laboratories (NYSE:RDY) recently announced the US launch of the generic version of Novartis AG’s (NYSE:NVS) Exelon. The drug is available worldwide as a treatment for Alzheimer’s disease... Read More
category RDY , NVS , Stocks , and 2 more.
from DailyMarkets.com
Watson Pharma Faces Lawsuit Heat
September 23, 2011
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and Novartis AG (NYSE:NVS) filed a lawsuit against Amphastar Pharmaceuticals, Inc. and Watson Pharmaceuticals Inc. (NYSE:WPI) regarding the generic version... Read More
category NVS , AZN , SNY , and 5 more.
from DailyMarkets.com
Mylan Settles With Roche For Xeloda
September 22, 2011
Mylan Inc. (NYSE:MYL) recently announced that it has entered into a settlement and license agreement with Roche (RHHBY) bringing an end to its ongoing litigation with the latter relating to Roche’s... Read More
category PRX , NVS , RHHBY , and 6 more.
from DailyMarkets.com
Novartis Unveils Upbeat ACZ885 Data
September 22, 2011
Novartis (NYSE:NVS) recently presented positive data from a pivotal trial studying its drug ACZ885 for the treatment of systemic juvenile idiopathic arthritis (SJIA), the most severe form of arthritis... Read More
category NVS , Stocks , External Research , and 1 more.
from DailyMarkets.com
Pharma Stocks Wrap Up - Lower: TEVA, NVS, SNY
September 21, 2011
New York, September 21st (TradersHuddle.com) - The market ended the trading session lower with the S&P 500 losing 2.94%. Stocks of Pharmaceutical Companies also traded lower, with NYSE Drug index... Read More
from TradersHuddle.com
(NVS) Novartis Drug Cleared in European Union for SEGA
September 20, 2011
Novartis (NVS) recently received a boost when its drug Votubia was approved for the treatment of... Visit StockBlogHub to view complete post. Read More
category TS , HCC , Tenaris SA , and 13 more.
from Stock Blog Hub
AstraZeneca - Best Performing Pharmaceutical
September 16, 2011
New York, September 16th (TradersHuddle.com) - At the half of the trading session the market is trading higher with the S&P 500 adding 0.23%. Stocks of Pharmaceutical Companies are also trading higher,... Read More
from TradersHuddle.com
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
27 28 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here